Efficacy of Epidural Analgesia in Lower Extremity Osteosarcoma

NCT ID: NCT04945512

Last Updated: 2021-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-07

Study Completion Date

2022-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators aim to reduce complications in orthopedic malignancy surgeries and to increase the quality of life of patients who will be operated on.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the preoperative period, the participants will be taken to the block room. The participants will be monitored, standard sedation will be applied.

Patients in the first group will be provided with preoperative and peroperative analgesia with an epidural catheter. The second group patient will be get no block. Afterwards, both groups will be operated under similar general anesthesia conditions. A patient-controlled analgesia device will be attached to each group of participants and their postoperative follow-up will be made.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteosarcoma Analgesia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

epidural analgesia lower extremity osteosarcoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Study group and control group
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group; Epidural catheter and PCA

Epidural catheter will be placed in the preoperative period. After induction, 10 ml of 0.25% bupivacaine will be administered through the epidural catheter and bupivacaine PCA will be started.

Group Type EXPERIMENTAL

Epidural Analgesia

Intervention Type PROCEDURE

In the anesthesia preparation room, an epidutal catheter will be placed with a toue needle through the L4-5 spinal space. After induction of general anesthesia, 10 ml of 0.25% bupivacaine will be injected through the epidural catheter.Afterwards, peroperative and postoperative analgesia will be provided with epidural PCA.

Control group; No block, IC PCA

Postoperative pain control will be achieved with intravenous morphine PCA.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Epidural Analgesia

In the anesthesia preparation room, an epidutal catheter will be placed with a toue needle through the L4-5 spinal space. After induction of general anesthesia, 10 ml of 0.25% bupivacaine will be injected through the epidural catheter.Afterwards, peroperative and postoperative analgesia will be provided with epidural PCA.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* accepting the study protocol,
* age older than 18 years and younger than 80 years,
* undergoing lower extremity osteosarcoma surgery
* the American Society of Anesthesiologist (ASA) physical status of I-II-III

Exclusion Criteria

* infection at the injection site
* coagulation disorder
* patients with central nervous system related disease
* septic patients
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nur Canbolat

Principle Invastigator, M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gizem Toydemir, MD

Role: PRINCIPAL_INVESTIGATOR

Istanbul Unıversity, Istanbul Faculty of Medicine, Anesthesiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul University, Faculty of Medicine

Istanbul, Fatih, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nur Canbolat, MD

Role: CONTACT

Phone: +905325162583

Email: [email protected]

Mehmet Büget, Assoc. Prof.

Role: CONTACT

Phone: +905324133282

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nur Canbolat, MD

Role: primary

Mehmet Büget, Assoc. Prof

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Rawal N. Current issues in postoperative pain management. Eur J Anaesthesiol. 2016 Mar;33(3):160-71. doi: 10.1097/EJA.0000000000000366.

Reference Type RESULT
PMID: 26509324 (View on PubMed)

Weinbroum AA. Superiority of postoperative epidural over intravenous patient-controlled analgesia in orthopedic oncologic patients. Surgery. 2005 Nov;138(5):869-76. doi: 10.1016/j.surg.2005.05.004.

Reference Type RESULT
PMID: 16291387 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020/1831

Identifier Type: -

Identifier Source: org_study_id